Status:
NOT_YET_RECRUITING
Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma
Lead Sponsor:
Shaare Zedek Medical Center
Conditions:
Febrile Neutropenia
Sarcoma
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Chemotherapy-induced febrile neutropenia (CIFN) is a dangerous complication of many chemotherapy drugs, with current treatment with granulocyte colony-stimulating factors (G-CSFs) accompanied by adver...
Eligibility Criteria
Inclusion
- age 18-65 years
- diagnosed with sarcoma of any stage
- scheduled for doxorubicin-based chemotherapy
- function ECOG status score of 0-1
Exclusion
- not fulfilling all inclusion criteria
- unwilling or unable to provide written informed consent for study participation
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06500715
Start Date
January 1 2026
End Date
December 1 2027
Last Update
May 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shaare Zedek Medical Center
Jerusalem, Israel, 91031